A recent article published in Contemporary Clinical Trial Communications evaluates the considerations raised during the regulatory & ethics review of five ID #PlatformTrials: #ECRAIDPrime, #RECLAIM, #REMAPCAP, #RECOVERY, and #SNAP.
Explore the full article here bit.ly/4v0qSCH
#TrialInnovation
What if, in the next infectious disease outbreak, patients are:
🤒 Too sick to travel?
🦠 Unable to visit clinics & traditional research sites?
🏔️ Living in remote or underserved areas?
The #ECRAIDPrime trial demonstrates that research does not need to stop. Trials can come to the patient.
🤧 The EU-funded #ECRAIDPrime trial has randomised its first 3 remote patients in the #UK this flu season — launching a patient-centric approach to expand access and community participation. This is a big step for infectious disease trials in #PrimaryCare and #Europe. 🎉 Congrats to the Oxford team!
#ECRAIDPrime #PrimaryCareResearch @christophercbutler.bsky.social @lenniederde.bsky.social @oxprimarycare.bsky.social @umcutrecht.bsky.social @ox.ac.uk @ecrin.bsky.social
@ec.europa.eu @umcutrecht.bsky.social @ox.ac.uk @ecrin.bsky.social @oxprimarycare.bsky.social @christophercbutler.bsky.social
@vcstx.bsky.social @marcbonten.bsky.social #horizon2020
#respiratoryillness #Flu #ClinicalResearch #ECRAIDBase #ECRAIDPrime
The #ECRAIDPrime study is pleased to announce the addition of a third treatment to its ongoing adaptive platform trial in #primarycare and a key component of Europe’s #pandemicpreparedness. Read more on ecraid.eu/news/ecraid-...
Respiratory infections like #COVID place a huge strain on healthcare systems worldwide. The EU-funded #ECRAIDPrime study is exploring potential treatments for viral respiratory infections through a first-of-its-kind #adaptiveplatformtrial in primary care. Read more on www.ecraid.eu/news/ecraid-...
